Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study
Identifieur interne : 001207 ( Istex/Corpus ); précédent : 001206; suivant : 001208Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study
Auteurs : Selvaraj Aranganathan ; Jayabal Panneer Selvam ; NaliniSource :
- Journal of Pharmacy and Pharmacology [ 0022-3573 ] ; 2008-10.
Abstract
Hesperetin, an important bioactive compound in Chinese traditional medicine, has antioxidant and anticarcinogenic properties. Hesperetin is found in abundance in orange and grape juices (200–590 mg L−1) consumed in the daily diet. We have investigated the effect of different doses of hesperetin on faecal and colonic mucosal bacterial enzymes and aberrant crypt foci (ACF) in 1,2‐dimethylhydrazine (DMH)‐induced colon carcinogenesis in male Wistar rats. The rats were divided into six groups and were fed a modified pellet diet for 16 weeks. Group 1 served as control and group 2 received the modified pellet diet along with hesperetin (30 mg kg−1). The rats in groups 3–6 rats were given a weekly subcutaneous injection of DMH (20 mg kg−1) for the first four weeks. Hesperetin was supplemented orally at different doses (10, 20 or 30 mg kg−1) for a total of 16 weeks. At the end of the experimental period all rats were killed. In DMH‐treated rats, the activity of faecal and colonic mucosal bacterial enzymes, such as β‐glucuronidase, β‐galactosidase, β‐glucosidase, nitroreductase, sulfatase and mucinase, were significantly elevated, but in rats supplemented hesperetin along with DMH the activity was significantly lowered (P < 0.05). The total number of aberrant crypts was significantly increased in unsupplemented DMH‐treated rats, while hesperetin supplementation to DMH‐treated rats significantly reduced the total number of crypts. The results demonstrated that hesperetin supplementation at a dose of 20 mg kg−1 played a potent role in suppressing the formation of aberrant crypt foci and reducing the activity of bacterial enzymes in colon cancer.
Url:
DOI: 10.1211/jpp.60.10.0015
Links to Exploration step
ISTEX:C7D4364826797729BCB24A12C9A78DF4376B0D9BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title><author><name sortKey="Aranganathan, Selvaraj" sort="Aranganathan, Selvaraj" uniqKey="Aranganathan S" first="Selvaraj" last="Aranganathan">Selvaraj Aranganathan</name><affiliation><mods:affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</mods:affiliation></affiliation></author><author><name sortKey="Selvam, Jayabal Panneer" sort="Selvam, Jayabal Panneer" uniqKey="Selvam J" first="Jayabal Panneer" last="Selvam">Jayabal Panneer Selvam</name><affiliation><mods:affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</mods:affiliation></affiliation></author><author><name sortKey="Nalini" sort="Nalini" uniqKey="Nalini" last="Nalini">Nalini</name><affiliation><mods:affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C7D4364826797729BCB24A12C9A78DF4376B0D9B</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1211/jpp.60.10.0015</idno><idno type="url">https://api.istex.fr/document/C7D4364826797729BCB24A12C9A78DF4376B0D9B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001207</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title><author><name sortKey="Aranganathan, Selvaraj" sort="Aranganathan, Selvaraj" uniqKey="Aranganathan S" first="Selvaraj" last="Aranganathan">Selvaraj Aranganathan</name><affiliation><mods:affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</mods:affiliation></affiliation></author><author><name sortKey="Selvam, Jayabal Panneer" sort="Selvam, Jayabal Panneer" uniqKey="Selvam J" first="Jayabal Panneer" last="Selvam">Jayabal Panneer Selvam</name><affiliation><mods:affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</mods:affiliation></affiliation></author><author><name sortKey="Nalini" sort="Nalini" uniqKey="Nalini" last="Nalini">Nalini</name><affiliation><mods:affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Pharmacy and Pharmacology</title><idno type="ISSN">0022-3573</idno><idno type="eISSN">2042-7158</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2008-10">2008-10</date><biblScope unit="volume">60</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1385">1385</biblScope><biblScope unit="page" to="1392">1392</biblScope></imprint><idno type="ISSN">0022-3573</idno></series><idno type="istex">C7D4364826797729BCB24A12C9A78DF4376B0D9B</idno><idno type="DOI">10.1211/jpp.60.10.0015</idno><idno type="ArticleID">JPHP2054</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3573</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Hesperetin, an important bioactive compound in Chinese traditional medicine, has antioxidant and anticarcinogenic properties. Hesperetin is found in abundance in orange and grape juices (200–590 mg L−1) consumed in the daily diet. We have investigated the effect of different doses of hesperetin on faecal and colonic mucosal bacterial enzymes and aberrant crypt foci (ACF) in 1,2‐dimethylhydrazine (DMH)‐induced colon carcinogenesis in male Wistar rats. The rats were divided into six groups and were fed a modified pellet diet for 16 weeks. Group 1 served as control and group 2 received the modified pellet diet along with hesperetin (30 mg kg−1). The rats in groups 3–6 rats were given a weekly subcutaneous injection of DMH (20 mg kg−1) for the first four weeks. Hesperetin was supplemented orally at different doses (10, 20 or 30 mg kg−1) for a total of 16 weeks. At the end of the experimental period all rats were killed. In DMH‐treated rats, the activity of faecal and colonic mucosal bacterial enzymes, such as β‐glucuronidase, β‐galactosidase, β‐glucosidase, nitroreductase, sulfatase and mucinase, were significantly elevated, but in rats supplemented hesperetin along with DMH the activity was significantly lowered (P < 0.05). The total number of aberrant crypts was significantly increased in unsupplemented DMH‐treated rats, while hesperetin supplementation to DMH‐treated rats significantly reduced the total number of crypts. The results demonstrated that hesperetin supplementation at a dose of 20 mg kg−1 played a potent role in suppressing the formation of aberrant crypt foci and reducing the activity of bacterial enzymes in colon cancer.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Selvaraj Aranganathan</name><affiliations><json:string>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</json:string></affiliations></json:item><json:item><name>Jayabal Panneer Selvam</name><affiliations><json:string>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</json:string></affiliations></json:item><json:item><name>Dr. Nalini</name><affiliations><json:string>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</json:string></affiliations></json:item></author><articleId><json:string>JPHP2054</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Hesperetin, an important bioactive compound in Chinese traditional medicine, has antioxidant and anticarcinogenic properties. Hesperetin is found in abundance in orange and grape juices (200–590 mg L−1) consumed in the daily diet. We have investigated the effect of different doses of hesperetin on faecal and colonic mucosal bacterial enzymes and aberrant crypt foci (ACF) in 1,2‐dimethylhydrazine (DMH)‐induced colon carcinogenesis in male Wistar rats. The rats were divided into six groups and were fed a modified pellet diet for 16 weeks. Group 1 served as control and group 2 received the modified pellet diet along with hesperetin (30 mg kg−1). The rats in groups 3–6 rats were given a weekly subcutaneous injection of DMH (20 mg kg−1) for the first four weeks. Hesperetin was supplemented orally at different doses (10, 20 or 30 mg kg−1) for a total of 16 weeks. At the end of the experimental period all rats were killed. In DMH‐treated rats, the activity of faecal and colonic mucosal bacterial enzymes, such as β‐glucuronidase, β‐galactosidase, β‐glucosidase, nitroreductase, sulfatase and mucinase, were significantly elevated, but in rats supplemented hesperetin along with DMH the activity was significantly lowered (P > 0.05). The total number of aberrant crypts was significantly increased in unsupplemented DMH‐treated rats, while hesperetin supplementation to DMH‐treated rats significantly reduced the total number of crypts. The results demonstrated that hesperetin supplementation at a dose of 20 mg kg−1 played a potent role in suppressing the formation of aberrant crypt foci and reducing the activity of bacterial enzymes in colon cancer.</abstract><qualityIndicators><score>7.88</score><pdfVersion>1.3</pdfVersion><pdfPageSize>579.97 x 764.22 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1661</abstractCharCount><pdfWordCount>4880</pdfWordCount><pdfCharCount>31292</pdfCharCount><pdfPageCount>8</pdfPageCount><abstractWordCount>252</abstractWordCount></qualityIndicators><title>Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title><genre><json:string>article</json:string></genre><host><volume>60</volume><publisherId><json:string>JPHP</json:string></publisherId><pages><total>8</total><last>1392</last><first>1385</first></pages><issn><json:string>0022-3573</json:string></issn><issue>10</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>2042-7158</json:string></eissn><title>Journal of Pharmacy and Pharmacology</title><doi><json:string>10.1111/(ISSN)2042-7158</json:string></doi></host><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1211/jpp.60.10.0015</json:string></doi><id>C7D4364826797729BCB24A12C9A78DF4376B0D9B</id><score>0.19292587</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/C7D4364826797729BCB24A12C9A78DF4376B0D9B/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/C7D4364826797729BCB24A12C9A78DF4376B0D9B/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/C7D4364826797729BCB24A12C9A78DF4376B0D9B/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>2008 Royal Pharmaceutical Society of Great Britain</p></availability><date>2008</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title><author xml:id="author-1"><persName><forename type="first">Selvaraj</forename><surname>Aranganathan</surname></persName><affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</affiliation></author><author xml:id="author-2"><persName><forename type="first">Jayabal Panneer</forename><surname>Selvam</surname></persName><affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</affiliation></author><author xml:id="author-3"><persName><surname>Nalini</surname></persName><roleName type="degree">Dr.</roleName><note type="correspondence"><p>Correspondence: *Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India. E‐mail:</p></note><affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</affiliation></author></analytic><monogr><title level="j">Journal of Pharmacy and Pharmacology</title><idno type="pISSN">0022-3573</idno><idno type="eISSN">2042-7158</idno><idno type="DOI">10.1111/(ISSN)2042-7158</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2008-10"></date><biblScope unit="volume">60</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1385">1385</biblScope><biblScope unit="page" to="1392">1392</biblScope></imprint></monogr><idno type="istex">C7D4364826797729BCB24A12C9A78DF4376B0D9B</idno><idno type="DOI">10.1211/jpp.60.10.0015</idno><idno type="ArticleID">JPHP2054</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Hesperetin, an important bioactive compound in Chinese traditional medicine, has antioxidant and anticarcinogenic properties. Hesperetin is found in abundance in orange and grape juices (200–590 mg L−1) consumed in the daily diet. We have investigated the effect of different doses of hesperetin on faecal and colonic mucosal bacterial enzymes and aberrant crypt foci (ACF) in 1,2‐dimethylhydrazine (DMH)‐induced colon carcinogenesis in male Wistar rats. The rats were divided into six groups and were fed a modified pellet diet for 16 weeks. Group 1 served as control and group 2 received the modified pellet diet along with hesperetin (30 mg kg−1). The rats in groups 3–6 rats were given a weekly subcutaneous injection of DMH (20 mg kg−1) for the first four weeks. Hesperetin was supplemented orally at different doses (10, 20 or 30 mg kg−1) for a total of 16 weeks. At the end of the experimental period all rats were killed. In DMH‐treated rats, the activity of faecal and colonic mucosal bacterial enzymes, such as β‐glucuronidase, β‐galactosidase, β‐glucosidase, nitroreductase, sulfatase and mucinase, were significantly elevated, but in rats supplemented hesperetin along with DMH the activity was significantly lowered (P < 0.05). The total number of aberrant crypts was significantly increased in unsupplemented DMH‐treated rats, while hesperetin supplementation to DMH‐treated rats significantly reduced the total number of crypts. The results demonstrated that hesperetin supplementation at a dose of 20 mg kg−1 played a potent role in suppressing the formation of aberrant crypt foci and reducing the activity of bacterial enzymes in colon cancer.</p></abstract></profileDesc><revisionDesc><change when="2008-10">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/C7D4364826797729BCB24A12C9A78DF4376B0D9B/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)2042-7158</doi><issn type="print">0022-3573</issn><issn type="electronic">2042-7158</issn><idGroup><id type="product" value="JPHP"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="JOURNAL OF PHARMACY AND PHARMACOLOGY">Journal of Pharmacy and Pharmacology</title></titleGroup></publicationMeta><publicationMeta level="part" position="10010"><doi origin="wiley">10.1111/jphp.2008.60.issue-10</doi><numberingGroup><numbering type="journalVolume" number="60">60</numbering><numbering type="journalIssue" number="10">10</numbering></numberingGroup><coverDate startDate="2008-10">October 2008</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="16" status="forIssue"><doi origin="wiley">10.1211/jpp.60.10.0015</doi><idGroup><id type="unit" value="JPHP2054"></id></idGroup><countGroup><count type="pageTotal" number="8"></count></countGroup><titleGroup><title type="tocHeading1">Research Paper</title></titleGroup><copyright>2008 Royal Pharmaceutical Society of Great Britain</copyright><eventGroup><event type="firstOnline" date="2010-02-18"></event><event type="publishedOnlineFinalForm" date="2010-02-18"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-04"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-01"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-30"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="1385">1385</numbering><numbering type="pageLast" number="1392">1392</numbering></numberingGroup><correspondenceTo>*Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India. E‐mail: <email>nalininam@yahoo.com</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JPHP.JPHP2054.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received March 12, 2008 Accepted June 11,2008</unparsedEditorialHistory><countGroup><count type="referenceTotal" number="36"></count><count type="linksCrossRef" number="4"></count></countGroup><titleGroup><title type="main">Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>Selvaraj</givenNames><familyName>Aranganathan</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>Jayabal Panneer</givenNames><familyName>Selvam</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Namasivayam</givenNames><familyName>Nalini</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="IN"><unparsedAffiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Hesperetin, an important bioactive compound in Chinese traditional medicine, has antioxidant and anticarcinogenic properties. Hesperetin is found in abundance in orange and grape juices (200–590 mg L<sup>−1</sup>) consumed in the daily diet. We have investigated the effect of different doses of hesperetin on faecal and colonic mucosal bacterial enzymes and aberrant crypt foci (ACF) in 1,2‐dimethylhydrazine (DMH)‐induced colon carcinogenesis in male Wistar rats. The rats were divided into six groups and were fed a modified pellet diet for 16 weeks. Group 1 served as control and group 2 received the modified pellet diet along with hesperetin (30 mg kg<sup>−1</sup>). The rats in groups 3–6 rats were given a weekly subcutaneous injection of DMH (20 mg kg<sup>−1</sup>) for the first four weeks. Hesperetin was supplemented orally at different doses (10, 20 or 30 mg kg<sup>−1</sup>) for a total of 16 weeks. At the end of the experimental period all rats were killed. In DMH‐treated rats, the activity of faecal and colonic mucosal bacterial enzymes, such as β‐glucuronidase, β‐galactosidase, β‐glucosidase, nitroreductase, sulfatase and mucinase, were significantly elevated, but in rats supplemented hesperetin along with DMH the activity was significantly lowered (<i>P</i> < 0.05). The total number of aberrant crypts was significantly increased in unsupplemented DMH‐treated rats, while hesperetin supplementation to DMH‐treated rats significantly reduced the total number of crypts. The results demonstrated that hesperetin supplementation at a dose of 20 mg kg<sup>−1</sup> played a potent role in suppressing the formation of aberrant crypt foci and reducing the activity of bacterial enzymes in colon cancer.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study</title></titleInfo><name type="personal"><namePart type="given">Selvaraj</namePart><namePart type="family">Aranganathan</namePart><affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Jayabal Panneer</namePart><namePart type="family">Selvam</namePart><affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Nalini</namePart><affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India</affiliation><description>Correspondence: *Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608 002, Tamilnadu, India. E‐mail: </description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2008-10</dateIssued><edition>Received March 12, 2008 Accepted June 11,2008</edition><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">36</extent></physicalDescription><abstract lang="en">Hesperetin, an important bioactive compound in Chinese traditional medicine, has antioxidant and anticarcinogenic properties. Hesperetin is found in abundance in orange and grape juices (200–590 mg L−1) consumed in the daily diet. We have investigated the effect of different doses of hesperetin on faecal and colonic mucosal bacterial enzymes and aberrant crypt foci (ACF) in 1,2‐dimethylhydrazine (DMH)‐induced colon carcinogenesis in male Wistar rats. The rats were divided into six groups and were fed a modified pellet diet for 16 weeks. Group 1 served as control and group 2 received the modified pellet diet along with hesperetin (30 mg kg−1). The rats in groups 3–6 rats were given a weekly subcutaneous injection of DMH (20 mg kg−1) for the first four weeks. Hesperetin was supplemented orally at different doses (10, 20 or 30 mg kg−1) for a total of 16 weeks. At the end of the experimental period all rats were killed. In DMH‐treated rats, the activity of faecal and colonic mucosal bacterial enzymes, such as β‐glucuronidase, β‐galactosidase, β‐glucosidase, nitroreductase, sulfatase and mucinase, were significantly elevated, but in rats supplemented hesperetin along with DMH the activity was significantly lowered (P < 0.05). The total number of aberrant crypts was significantly increased in unsupplemented DMH‐treated rats, while hesperetin supplementation to DMH‐treated rats significantly reduced the total number of crypts. The results demonstrated that hesperetin supplementation at a dose of 20 mg kg−1 played a potent role in suppressing the formation of aberrant crypt foci and reducing the activity of bacterial enzymes in colon cancer.</abstract><relatedItem type="host"><titleInfo><title>Journal of Pharmacy and Pharmacology</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0022-3573</identifier><identifier type="eISSN">2042-7158</identifier><identifier type="DOI">10.1111/(ISSN)2042-7158</identifier><identifier type="PublisherID">JPHP</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>60</number></detail><detail type="issue"><caption>no.</caption><number>10</number></detail><extent unit="pages"><start>1385</start><end>1392</end><total>8</total></extent></part></relatedItem><identifier type="istex">C7D4364826797729BCB24A12C9A78DF4376B0D9B</identifier><identifier type="DOI">10.1211/jpp.60.10.0015</identifier><identifier type="ArticleID">JPHP2054</identifier><accessCondition type="use and reproduction" contentType="copyright">2008 Royal Pharmaceutical Society of Great Britain</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><enrichments><json:item><type>multicat</type><uri>https://api.istex.fr/document/C7D4364826797729BCB24A12C9A78DF4376B0D9B/enrichments/multicat</uri></json:item></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Bois/explor/OrangerV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001207 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001207 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Bois
|area= OrangerV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:C7D4364826797729BCB24A12C9A78DF4376B0D9B
|texte= Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen‐induced aberrant crypt foci in colon cancer rats: a dose‐dependent study
}}
| This area was generated with Dilib version V0.6.25. |  |